Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy

Figure 2

Anti-PLA2R AB and proteinuria in patients with primary membranous nephropathy after rituximab administration (data from Beck et al. [40]).